SJS Investment Consulting’s Abiomed Inc ABMD Stock Holding History

SJS Investment Consulting’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-4	Closed	–	–	1733
2022 Q3	$0	Buy	+4	New	+$1.08K	﹤0.01%	1691
2022 Q1	$0	Buy	+1	New	+$308	﹤0.01%	1479

Other funds holding ABMD

TRSOTSOK

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

SJS Investment Consulting's ABMD Position: Q4 2022 in Review

SJS Investment Consulting sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 4 shares.

SJS Investment Consulting first reported a position in ABMD in Q1 2022 and held it in 2 quarters. The position peaked at $0 in Q3 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

SJS Investment Consulting reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
SJS Investment Consulting sold 4 Abiomed Inc shares in Q4 2022.
SJS Investment Consulting first reported a position in Abiomed Inc in Q1 2022 and held it in 2 quarters.
SJS Investment Consulting's Abiomed Inc position peaked at $0 in Q3 2022.
8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on SJS Investment Consulting's 13F filing for Q4 2022, filed 23 Jan 2023.